Entegris, Inc. · ENTG · FY2026 Q3 · Calendar Q4 2026
Entegris posts record Q3 as AI demand lifts growth and margins
Entegris' Q3 results support a constructive growth case: AI-driven advanced logic and memory demand, capacity unlocks and operating improvements drove record revenue, higher margins and stronger backlog. The case still depends on semiconductor capital spending, supply-chain execution and successful facility ramps.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about ENTG FY2026 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Revenue reached a record $1.006 billion, up 25% year over year, while adjusted gross margin expanded to 48.9% and adjusted EBITDA margin exceeded 30%. Book-to-bill remained well above 1, backlog rose more than 35% sequentially and doubled year over year, and 2026 capex guidance was reduced to approximately $200 million.
Guidance delta
Management maintained its outlook, pointing to continued FY 2026 growth, an upbeat Q4 view and lower 2026 capex. The company also outlined ongoing ramps at KSP South and Colorado.
Key takeaways
- Record Q3 revenue grew 25% year over year to $1.006 billion.
- Adjusted gross margin reached 48.9%, up 530 basis points year over year, while adjusted EBITDA margin exceeded 30%.
- APS grew 31% year over year and both APS and MS delivered double-digit growth.
- Book-to-bill stayed well above 1, with backlog up more than 35% sequentially and doubled year over year.
- KSP reached gross-profit breakeven in Q3, while 2026 capex guidance fell to approximately $200 million.
Management priorities
- Expand brownfield capacity while reducing planned 2026 capex.
- Ramp KSP South toward breakeven and bring the Colorado facility to revenue generation in 2027.
- Continue early customer engagement to secure plan-of-record wins.
- Use productivity, yield and procurement initiatives to support margins.
- Detail the AI-native strategy and long-term roadmap at the November 9 Capital Markets Day.
Follow ENTG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Needham | Buy | Buy | Maintain | Oct 29, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 20, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Aug 12, 2026 |
| UBS | Buy | Buy | Maintain | Aug 5, 2026 |
| Oppenheimer | Outperform | Perform | Upgrade | Aug 5, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 6, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 1, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Feb 11, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Feb 11, 2026 |
| Seaport Global | Neutral | Buy | Downgrade | Jan 23, 2026 |
| Craig-Hallum | Buy | Buy | Maintain | Nov 5, 2024 |
| Loop Capital | Buy | Buy | Maintain | May 15, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 15, 2023 |
| Stifel | Buy | Buy | Maintain | Aug 16, 2022 |
| Wolfe Research | Outperform | Outperform | Maintain | Jun 10, 2021 |
| CL King | Buy | Buy | Maintain | Jun 21, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jul 2, 2018 |
| Aegis Capital | Buy | Buy | Maintain | Mar 17, 2017 |
| Pacific Crest | Overweight | Overweight | Maintain | Jul 28, 2016 |
| Dougherty & Co. | Neutral | Buy | Downgrade | Jul 28, 2016 |
| Dougherty | Neutral | Buy | Downgrade | Jul 28, 2016 |
| Sidoti & Co. | Neutral | Buy | Downgrade | Jul 1, 2015 |
| DA Davidson | Buy | Buy | Maintain | Feb 5, 2014 |
| Northland Securities | Perform | Market Perform | Maintain | Aug 28, 2013 |
| Bank of America | Neutral | Neutral | Maintain | Oct 24, 2012 |
| B of A Securities | Neutral | Neutral | Maintain | Oct 24, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $160. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $190 | $161.16 | +18.8% | Oct 14, 2026 |
| Barclays | Aleksey Yefremov | $212 | $160.01 | +32.5% | Oct 12, 2026 |
| Stifel Nicolaus | Analyst unavailable | $200 | $166.32 | +25.0% | Oct 7, 2026 |
| Deutsche Bank | Melissa Weathers | $200 | $150.21 | +25.0% | Aug 12, 2026 |
| Deutsche Bank | Analyst unavailable | $152 | $144.67 | -5.0% | Aug 5, 2026 |
| UBS | Timothy Arcuri | $215 | $144.22 | +34.4% | Aug 5, 2026 |
| Oppenheimer | Ed Yang | $180 | $144.56 | +12.5% | Aug 5, 2026 |
| Deutsche Bank | Melissa Weathers | $155 | $154 | -3.1% | Jul 6, 2026 |
| BMO Capital | Bhavesh Lodaya | $167 | $146.66 | +4.4% | Jul 6, 2026 |
| Mizuho Securities | John Roberts | $200 | $179.86 | +25.0% | Jul 1, 2026 |
| Mizuho Securities | John Roberts | $180 | $138.44 | +12.5% | May 29, 2026 |
| Goldman Sachs | James Schneider | $115 | $140.84 | -28.1% | May 1, 2026 |
| UBS | Analyst unavailable | $205 | $140.5 | +28.1% | May 1, 2026 |
| Mizuho Securities | John Roberts | $175 | $140.81 | +9.4% | May 1, 2026 |
| Oppenheimer | Edward Yang | $160 | $140.6 | +0.0% | May 1, 2026 |
| UBS | Analyst unavailable | $185 | $148.92 | +15.6% | Apr 21, 2026 |
| Mizuho Securities | Analyst unavailable | $150 | $136.84 | -6.3% | Feb 11, 2026 |
| KeyBanc | Aleksey Yefremov | $156 | $135.7 | -2.5% | Feb 11, 2026 |
| Goldman Sachs | Analyst unavailable | $95 | $133.44 | -40.6% | Feb 11, 2026 |
| BMO Capital | Analyst unavailable | $148 | $133.44 | -7.5% | Feb 11, 2026 |
| Deutsche Bank | Analyst unavailable | $105 | $113.7 | -34.4% | Feb 3, 2026 |
| UBS | Analyst unavailable | $150 | $120.29 | -6.3% | Feb 2, 2026 |
| BMO Capital | Analyst unavailable | $126 | $118.46 | -21.3% | Jan 21, 2026 |
| UBS | Timothy Arcuri | $145 | $104.09 | -9.4% | Jan 15, 2026 |
| KeyBanc | Aleksey Yefremov | $111 | $99.85 | -30.6% | Jan 9, 2026 |
| Goldman Sachs | Analyst unavailable | $75 | $92.52 | -53.1% | Dec 15, 2025 |
| Mizuho Securities | Analyst unavailable | $96 | $73.76 | -40.0% | Nov 20, 2025 |
| Mizuho Securities | Analyst unavailable | $108 | $96.81 | -32.5% | Oct 3, 2025 |
| Oppenheimer | Edward Yang | $95 | $79.65 | -40.6% | Sep 4, 2025 |
| KeyBanc | Aleksey Yefremov | $103 | $79.34 | -35.6% | Jul 31, 2025 |
| BMO Capital | Bhavesh Lodaya | $135 | $101.72 | -15.6% | Nov 5, 2024 |
| Needham | Charles Shi | $120 | $101.72 | -25.0% | Nov 5, 2024 |
| KeyBanc | Aleksey Yefremov | $154 | $101.72 | -3.8% | Nov 5, 2024 |
| Citigroup | Atif Malik | $130 | $110.67 | -18.8% | Sep 16, 2024 |
| C.L. King | David Silver | $150 | $116.1 | -6.3% | Aug 23, 2024 |
| BMO Capital | Bhavesh Lodaya | $145 | $118.29 | -9.4% | Aug 1, 2024 |
| Mizuho Securities | John Roberts | $143 | $109.88 | -10.6% | Aug 1, 2024 |
| Seaport Global | Michael Harrison | $150 | $118.29 | -6.3% | Jul 31, 2024 |
| Deutsche Bank | Melissa Weathers | $160 | $137.73 | +0.0% | Jun 20, 2024 |
| Needham | Charles Shi | $150 | $132.36 | -6.3% | May 28, 2024 |
| Craig-Hallum | Christian Schwab | $150 | $135.65 | -6.3% | Feb 15, 2024 |
| Loop Capital Markets | Bhavesh Lodaya | $129 | $106.5 | -19.4% | Jun 20, 2023 |
| Needham | Analyst unavailable | $86 | $64.13 | -46.3% | Jan 4, 2023 |
| Craig-Hallum | Christian Schwab | $120 | $87.09 | -25.0% | Sep 23, 2022 |
| Mizuho Securities | Kieran de Brun | $148 | $104.53 | -7.5% | Aug 15, 2022 |
| Stifel Nicolaus | Patrick Ho | $180 | $148.54 | +12.5% | Dec 1, 2021 |
| C.L. King | David C Silver | $130 | $121.52 | -18.8% | Sep 7, 2021 |
| Piper Sandler | Weston Twigg | $126 | $114.55 | -21.3% | Apr 28, 2021 |
Track every rating change on ENTG the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationEntegris, Inc. is a global enterprise that develops, manufactures, and supplies critical solutions for microcontamination control, specialty chemicals, and advanced material handling. The company operates extensively across North America, Taiwan, China, South Korea, Japan, Europe, and Southeast Asia. Its operations are structured into three primary segments: Specialty Chemicals and Engineered Materials (SCEM): This division delivers high-performance, ultra-pure process chemistries, specialized gases, and advanced materials, along with their associated delivery systems, crucial for semiconductor fabrication and other sophisticated manufacturing processes. Microcontamination Control (MC): The MC unit focuses on providing systems designed to filter and purify essential liquid chemicals and gases utilized within the semiconductor industry and various other high-technology sectors.…
Technology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ASX ASE Technology Holding Co., Ltd. | FY2026 Q3 · Calendar Q4 2026 | +8.8% | +1.4% | ASE’s LEAP ramp drives record quarter, but capacity is tight |
| TYL Tyler Technologies, Inc. | FY2026 Q3 · Calendar Q4 2026 | +1.1% | +3.6% | Tyler maintains guidance as SaaS growth and AI adoption advance |
| CTSH Cognizant Technology Solutions Corporation | FY2026 Q3 · Calendar Q4 2026 | — | -6.0% | Cognizant posts 4.8% growth as AI-led services expand |
Latest beats and misses
Who reports nextBeat on EPS
- DTMFY2026 Q3 · October 29, 2026+2.7% EPS+1.7% move
- TAKFY2026 Q2 · October 29, 2026+251.7% EPS-0.7% move
- BLDRFY2026 Q3 · October 29, 2026+42.5% EPS+12.8% move
- HIIFY2026 Q3 · October 29, 2026+25.7% EPS+13.2% move
- KIM-PNFY2026 Q3 · October 29, 2026+101.6% EPS— move
- FLSFY2026 Q3 · October 28, 2026+9.0% EPS+11.9% move
Missed on EPS
- SCIFY2026 Q3 · October 28, 2026-2.1% EPS-8.7% move
- AMFY2026 Q3 · October 28, 2026-5.6% EPS+3.7% move
- INGFY2026 Q3 · October 29, 2026-5.1% EPS-2.0% move
- AMPFY2026 Q3 · October 29, 2026-4.3% EPS+1.7% move
- AMRZFY2026 Q3 · October 28, 2026-1.0% EPS+3.9% move
- MAAFY2026 Q3 · October 28, 2026-5.9% EPS+1.3% move
Get the ENTG recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-29T18:06:38.918092+00:00
- FN2 earnings calendar · 2026-10-30T01:23:13.979536+00:00
- Polygon adjusted daily market bars · 2026-10-30T03:20:43.549462+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-30T03:20:43.546503+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-30. For educational purposes only; not investment advice.